Kerner Berit
Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Appl Clin Genet. 2014 Feb 12;7:33-42. doi: 10.2147/TACG.S39297. eCollection 2014.
Bipolar disorder is a common, complex genetic disorder, but the mode of transmission remains to be discovered. Many researchers assume that common genomic variants carry some risk for manifesting the disease. The research community has celebrated the first genome-wide significant associations between common single nucleotide polymorphisms (SNPs) and bipolar disorder. Currently, attempts are under way to translate these findings into clinical practice, genetic counseling, and predictive testing. However, some experts remain cautious. After all, common variants explain only a very small percentage of the genetic risk, and functional consequences of the discovered SNPs are inconclusive. Furthermore, the associated SNPs are not disease specific, and the majority of individuals with a "risk" allele are healthy. On the other hand, population-based genome-wide studies in psychiatric disorders have rediscovered rare structural variants and mutations in genes, which were previously known to cause genetic syndromes and monogenic Mendelian disorders. In many Mendelian syndromes, psychiatric symptoms are prevalent. Although these conditions do not fit the classic description of any specific psychiatric disorder, they often show nonspecific psychiatric symptoms that cross diagnostic boundaries, including intellectual disability, behavioral abnormalities, mood disorders, anxiety disorders, attention deficit, impulse control deficit, and psychosis. Although testing for chromosomal disorders and monogenic Mendelian disorders is well established, testing for common variants is still controversial. The standard concept of genetic testing includes at least three broad criteria that need to be fulfilled before new genetic tests should be introduced: analytical validity, clinical validity, and clinical utility. These criteria are currently not fulfilled for common genomic variants in psychiatric disorders. Further work is clearly needed before genetic testing for common variants in psychiatric disorders should be established.
双相情感障碍是一种常见的、复杂的遗传性疾病,但其传播方式仍有待发现。许多研究人员认为,常见的基因组变异会增加患该疾病的风险。研究界对常见单核苷酸多态性(SNP)与双相情感障碍之间首次出现的全基因组显著关联表示欢迎。目前,正在尝试将这些发现应用于临床实践、遗传咨询和预测性检测。然而,一些专家仍持谨慎态度。毕竟,常见变异仅解释了遗传风险的很小一部分,而且已发现的SNP的功能后果尚无定论。此外,相关的SNP并非疾病特异性的,大多数携带“风险”等位基因的个体是健康的。另一方面,基于人群的精神疾病全基因组研究重新发现了基因中的罕见结构变异和突变,这些变异和突变以前已知会导致遗传综合征和单基因孟德尔疾病。在许多孟德尔综合征中,精神症状很普遍。尽管这些情况不符合任何特定精神疾病的经典描述,但它们通常表现出跨越诊断界限的非特异性精神症状,包括智力残疾、行为异常、情绪障碍、焦虑障碍、注意力缺陷、冲动控制缺陷和精神病。虽然对染色体疾病和单基因孟德尔疾病的检测已经很成熟,但对常见变异的检测仍存在争议。基因检测的标准概念至少包括三个广泛的标准,在引入新的基因检测之前需要满足这些标准:分析有效性、临床有效性和临床实用性。目前,精神疾病中常见基因组变异的这些标准尚未得到满足。在建立精神疾病常见变异的基因检测之前,显然还需要进一步的研究。